A UK study indicated less widespread use and that although smart pumps may be in use within an organisation, they may only be used in some clinical areas or for certain kinds of infusion.4 Although ...

A patient-controlled epidural analgesia (PCEA) pump was attached 30 min later, which was established with 250 mL of study drug mixture for maintenance (either 0.36 µg/mL dexmedetomidine plus 0.07% ...

The Food and Drug Administration issued Class I recalls, the most serious type, for two Smiths Medical infusion pumps due to the potential for serious injury or death. Certain CADD-Solis Ambulatory ...

Chicago, June 05, 2025 (GLOBE NEWSWIRE) -- The global elastomeric infusion pumps market was valued at US$ 741.56 million in 2024 and is expected to reach US$ 1,357.40 million by 2033, growing at a ...

Demand for elastomeric infusion pumps is accelerating on clinician convenience, home-care growth, sustainable materials innovation, and regulatory harmonization, while digital supply chains and ...

To resolve this issue, we developed a syringe pump controller that is capable of delivering different fluid volumes, in the range used in behavioral studies, over common periods of time. Here, we ...

The presented Syringe Pump utilizes a lead-screw mechanism that is driven by a stepper motor which itself is controlled by an electronic circuit based on an 89S52 microcontroller that works as the ...

Smiths Medical said the USO alarm, a high-priority alarm, interrupts an ongoing infusion or delays infusion initiation. The pump can’t resume or start an infusion until the alarm is cleared. Such an ...

Smiths Medical has recalled infusion pumps to update the instructions to address three problems that could lead to serious injury or death. The devices are staying on the market. The Food and Drug ...

Ingersoll Rand Inc has acquired Lead Fluid (Baoding) Intelligent Equipment Manufacturing Co Ltd, a China-based manufacturer of advanced fluid-handling products, including peristaltic pumps, syringe ...

Clinical intravenous errors. Wrong intravenous rate: administration of intravenous drug at a faster rate than recommended in the Australian Injectable Drugs Handbook (AIDH).15 Administration of ...